Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Oxycontin price, strengths & recalls

Brand of oxycodone (generic)

Pharmacies pay $176.23 for 30 tablets of Oxycontin 10 mg extended-release tablet this week, and from $176.23 to $979.21 across its 7 priced strengths and forms. The generic, oxycodone, costs pharmacies from $2.77. It has 21 recalls on record, none ongoing. Its official label last changed on June 26, 2026.

Brand
Pharmacies pay$176.23for 30 tablets of 10 mg extended-release tabletNo change in 4 weeks
Fair cash price
$213.16
Strengths
7
Makers
1
Updated
Nov 11

Oxycontin price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
10 mg extended-release tablet Brand$5.87$176.23 / 30 tabletsNo change+8.2%
15 mg extended-release tablet Brand$8.66$259.68 / 30 tablets-0.1%+8.4%
20 mg extended-release tablet Brand$10.95$328.60 / 30 tabletsNo change+8.4%
30 mg extended-release tablet Brand$15.22$456.72 / 30 tabletsNo change+8.3%
40 mg extended-release tablet Brand$18.77$563.14 / 30 tabletsNo change+8.4%
60 mg extended-release tablet Brand$26.53$796.03 / 30 tabletsNo change+8.5%
80 mg extended-release tablet Brand$32.64$979.21 / 30 tablets-0.1%+8.2%

The lowest cost per tablet is 10 mg extended-release tablet at $5.87. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Oxycontin vs generic oxycodone

GenericOxycodone prices

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
2 ongoing recalls21 recalls on record

Recalls

Showing the 6 most relevant of 21 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for oxycontin? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJune 26, 2026
Version44 of 31
EffectiveJun 24, 2026
Read the label

These highlights do not include all the information needed to use OXYCONTIN® safely and effectively. See full prescribing information for OXYCONTIN. OXYCONTIN® (oxycodone hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 1950

This drug has a boxed warning

WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF OXYCONTIN

Addiction, Abuse, and Misuse

Because the use of OXYCONTIN exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient's risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions [see Warnings and Precautions (5.1)].

Life-Threatening Respiratory Depression

Serious, life-threatening, or fatal respiratory depression may occur with use of OXYCONTIN, especially during initiation or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration of OXYCONTIN are essential. Instruct patients to swallow OXYCONTIN tablets whole; crushing, chewing, or dissolving OXYCONTIN tablets can cause rapid release and absorption of a potentially fatal dose of oxycodone [see Warnings and Precautions (5.2)].

Accidental Ingestion

Accidental ingestion of even one dose of OXYCONTIN, especially by children, can result in a fatal overdose of oxycodone [see Warnings and Precautions (5.2)].

Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants

Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of OXYCONTIN and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate [see Warnings and Precautions (5.3), Drug Interactions (7)].

Neonatal Opioid Withdrawal Syndrome (NOWS)

Advise pregnant women using opioids for an extended period of time of the risk of Neonatal Opioid Withdrawal Syndrome, which may be life-threatening if not recognized and treated. Ensure that management by neonatology experts will be available at delivery [see Warnings and Precautions (5.4)].

Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS)

Healthcare providers are strongly encouraged to complete a REMS-compliant education program and to counsel patients and caregivers on serious risks, safe use, and the importance of reading the Medication Guide with each prescription [see Warnings and Precautions (5.5)].

Cytochrome P450 3A4 Interaction

The concomitant use of OXYCONTIN with all cytochrome P450 3A4 inhibitors may result in an increase in oxycodone plasma concentrations, which could increase or prolong adverse drug effects and may cause potentially fatal respiratory depression. In addition, discontinuation of a concomitantly used cytochrome P450 3A4 inducer may result in an increase in oxycodone plasma concentration. Regularly evaluate patients receiving OXYCONTIN and any CYP3A4 inhibitor or inducer [see Warnings and Precautions (5.6), Drug Interactions (7), Clinical Pharmacology (12.3)].

WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF OXYCONTIN

See full prescribing information for complete boxed warning.

OXYCONTIN exposes users to risks of addiction, abuse, and misuse, which can lead to overdose and death. Assess patient's risk before prescribing and reassess regularly for these behaviors and conditions. (5.1)

Serious, life-threatening, or fatal respiratory depression may occur. Monitor closely, especially upon initiation or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration of OXYCONTIN are essential. Instruct patients to swallow OXYCONTIN tablets whole to avoid exposure to a potentially fatal dose of oxycodone. (5.2)

Accidental ingestion of OXYCONTIN, especially by children, can result in a fatal overdose of oxycodone. (5.2)

Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing for use in patients for whom alternative treatment options are inadequate. (5.3, 7)

Advise pregnant women using opioids for an extended period of time of the risk of Neonatal Opioid Withdrawal Syndrome, which may be life-threatening if not recognized and treated. Ensure that appropriate management by neonatology experts will be available at delivery. (5.4)

Healthcare providers are strongly encouraged to complete a REMS-compliant education program and to counsel patients and caregivers on serious risks, safe use, and the importance of reading the Medication Guide with each prescription. (5.5)

Concomitant use with CYP3A4 inhibitors (or discontinuation of CYP3A4 inducers) can result in a fatal overdose of oxycodone. (5.6, 7, 12.3)

Recent major changes (as listed on the label)

Boxed Warning | 12/2025 |

Indications and Usage (1) | 12/2025 |

Dosage and Administration (2.2, 2.3) | 12/2025 |

Warnings and Precautions (5.1, 5.2, 5.3, 5.13, 5.15) | 12/2025 |

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA022272 · Knoa Pharma
First approved
April 5, 2010 (16 years ago)
Latest approved change
June 18, 2026
Approved label
PDF, Jan 6, 2026
Generic makers
20 approved generic applications on the market
Last patent listed
March 29, 2030

Oxycontin questions

How much does oxycontin cost without insurance?

Pharmacies pay about $176.23 for 30 tablets of oxycontin 10 mg extended-release tablet ($5.87 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $213.16. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Oxycontin?

Yes: oxycodone. Pharmacies pay from $2.77 for it. Compare oxycodone prices.

Is oxycontin in shortage?

No shortage is reported for oxycontin right now. We check the national shortage list every day.

Has oxycontin been recalled?

21 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the oxycontin label last change?

The official label was last updated on June 26, 2026 (version 44). See what changed.

Talk about oxycontin

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.